CovalX Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 22


  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

CovalX General Information


Operator of a biotechnology company intended to provide technology and services in the field of protein interaction analysis based on mass spectrometry. The company develops innovative analysis alternatives for the characterization of therapeutic proteins and protein interactions for the life science industry, enabling pharmaceutical companies, life science industries, and academic laboratories to achieve high-quality results for the analysis of protein complexes, antibodies, and therapeutic proteins.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Other Healthcare Technology Systems
Other Healthcare Services
Corporate Office
  • Schützengasse 23
  • 8001 Zurich
  • Switzerland
+41 044 000 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CovalX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 00.000 Completed Generating Revenue
3. Grant 23-Aug-2011 00000 00.000 Completed Generating Revenue
2. Early Stage VC 09-Jun-2008 $1.66M $1.66M 00.000 Completed Generating Revenue
1. Spin-Off 01-Jan-2005 Completed Startup
To view CovalX’s complete valuation and funding history, request access »

CovalX Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 00.000
To view CovalX’s complete cap table history, request access »

CovalX Executive Team (4)

Name Title Board Seat Contact Info
Alexis Nazabal Ph.D Co-Founder, Chief Executive Officer, and Director of European and Asia Operations
Ryan Wenzel Ph.D Co-Founder, Vice Chairman, Director of North American Operations & Board Member
Jason Sumner National Sales Manager
Urs Matter Co-Founder
To view CovalX’s complete executive team members history, request access »

CovalX Board Members (4)

Name Representing Role Since
Mario Hochstrasser Self Board Member 000 0000
Philip Bodmer Self Board Member 000 0000
René Lenggenhager Self Chairman 000 0000
Ryan Wenzel Ph.D CovalX Co-Founder, Vice Chairman, Director of North American Operations & Board Member 000 0000
To view CovalX’s complete board members history, request access »

CovalX Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CovalX Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Swiss Confederation Commission for Technology and Innovation Government 000 0000 000000 0
StartAngels Network Angel Group Minority 000 0000 000000 0
To view CovalX’s complete investors history, request access »

CovalX FAQs

  • When was CovalX founded?

    CovalX was founded in 2005.

  • Who is the founder of CovalX?

    Alexis Nazabal Ph.D, Ryan Wenzel Ph.D, and Urs Matter are the founders of CovalX.

  • Who is the CEO of CovalX?

    Alexis Nazabal Ph.D is the CEO of CovalX.

  • Where is CovalX headquartered?

    CovalX is headquartered in Zurich, Switzerland.

  • What is the size of CovalX?

    CovalX has 22 total employees.

  • What industry is CovalX in?

    CovalX’s primary industry is Biotechnology.

  • Is CovalX a private or public company?

    CovalX is a Private company.

  • What is CovalX’s current revenue?

    The current revenue for CovalX is 00000.

  • How much funding has CovalX raised over time?

    CovalX has raised $1.66M.

  • Who are CovalX’s investors?

    Swiss Confederation Commission for Technology and Innovation and StartAngels Network have invested in CovalX.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »